Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosswog

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
The Journal of Molecular Diagnostics : JMD|October 19, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology StudyAlexandra Saint-Charles, Julien Masliah-Planchon, Elnaz Saberi-Ansari, et al.
Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Science (New York, N.Y.)|October 18, 2017
<i>Swift</i> and <i>NuSTAR</i> observations of GW170817: Detection of a blue kilonovaP A Evans, S B Cenko, J A Kennea, et al.
Genome Biology|June 26, 2015
Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Ying Yu, Falk Hertwig, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Nature Genetics|December 18, 2019
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
Molecular Cancer|June 10, 2022
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cellsMareike Berlak, Elizabeth Tucker, Mathurin Dorel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
<i>TERT</i> Expression and Clinical Outcome in Pulmonary CarcinoidsLisa Werr, Christoph Bartenhagen, Carolina Rosswog, et al.
Nature Genetics|February 29, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastomaRichard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, et al.
The Journal of Molecular Diagnostics : JMD|October 19, 2025
Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology StudyAlexandra Saint-Charles, Julien Masliah-Planchon, Elnaz Saberi-Ansari, et al.
Science (New York, N.Y.)|December 8, 2018
A mechanistic classification of clinical phenotypes in neuroblastomaSandra Ackermann, Maria Cartolano, Barbara Hero, et al.
The Journal of Clinical Investigation|February 12, 2026
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaLisa Werr, Jana Boland, Josephine Petersen, et al.
JCO Precision Oncology|July 1, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN StudyHannah E Hartley, Fang Chyi Fong, Alem S Gabriel, et al.
Science (New York, N.Y.)|October 18, 2017
<i>Swift</i> and <i>NuSTAR</i> observations of GW170817: Detection of a blue kilonovaP A Evans, S B Cenko, J A Kennea, et al.
Genome Biology|June 26, 2015
Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Ying Yu, Falk Hertwig, et al.
Pageof 4